When traditional methods like exercise and dieting fail to produce results, medications like Ozempic, Mounjaro, and Wegovy may offer a solution. Patients who have struggled to shed pounds are reporting positive outcomes with these weekly injections. Semaglutides, under the brand names Wegovy and Ozempic, were approved by the FDA for weight loss in 2021. While Ozempic is primarily used to treat Type 2 diabetes, it also offers weight loss as a side effect.
Mounjaro is another medication that shows promise as a weight loss aid. It is a tirzapatide and was initially approved by the FDA in 2022 as a diabetes treatment. It is likely to be approved for weight loss as well.
Patients like Stephanie Parris have found success with these injectable medications. Parris had struggled with weight gain after giving birth and tried various diets and exercise regimens without success. She also faced challenges with her mental health post-partum, which further contributed to her weight gain. After starting Mounjaro, Parris noticed a significant change in her body and lost 25 pounds in six months.
The way these medications work is by mimicking natural hormones in the body that regulate blood sugar, digestion, and hunger. This leads to appetite suppression and ultimately weight loss. However, it is crucial to be monitored by a healthcare professional when using these injectable weight loss medications due to the risk of muscle loss and intense side effects.
Pharmacist practitioner Katherine Zheveleva stresses the importance of caution when purchasing these drugs online or through social media. She warns of potential stomach side effects and advises starting at a low dose and gradually increasing to ensure tolerance.
Overall, while these medications offer promising results for weight loss, it is crucial to approach them with caution and under the guidance of a healthcare professional.
– WJXT News4JAX
– Thin MD Med Spa
– UF Health Jacksonville